About Pharm Assess
Pharm Assess is a company based in Overland Park (United States) founded in 1996 was acquired by Transaction Data Systems in April 2019. Pharm Assess offers products and services including Reconciliation, Premium Rx30, Telepharmacy, Vaccines, and Patient Engagement. Pharm Assess operates in a competitive market with competitors including One bio, Skila, Alter-Pharma, Aptitude Health and RxData, among others.
- Headquarter Overland Park, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Transaction Data Systems
(Apr 04, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pharm Assess
Pharm Assess offers a comprehensive portfolio of products and services, including Reconciliation, Premium Rx30, Telepharmacy, Vaccines, and Patient Engagement.
Tool for claim reconciliation and payment recovery in pharmacies.
Platform for pharmacy management and clinical service integration.
System for remote pharmacy operations and patient engagement.
Support for vaccine administration and tracking in pharmacies.
Tools to enhance patient communication and adherence programs.
Funding Insights of Pharm Assess
Detailed funding history for Pharm Assess
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Pharm Assess
Pharm Assess has secured backing from 1 investor. Prominent investors backing the company include Transaction Data Systems.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Software development services are provided to the biopharma sector.
|
Locked | Locked | Locked |
Investor details for Pharm Assess
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pharm Assess
Investment portfolio details for Pharm Assess
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pharm Assess
Detailed financials for Pharm Assess
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharm Assess Comparisons
Peer comparison for Pharm Assess
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pharm Assess
Pharm Assess operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as One bio, Skila, Alter-Pharma, Aptitude Health and RxData, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Online tools for partner management and opportunity screening.
|
|
| Locked | Locked | Locked |
Product launch and KOL management solutions for life sciences industry
|
|
| Locked | Locked | Locked |
Digital management software and services are provided for healthcare.
|
|
| Locked | Locked | Locked |
Business intelligence platform is provided for healthcare professionals and organizations.
|
|
| Locked | Locked | Locked |
Digital market intelligence for pharmaceuticals is provided by RxData.
|
|
| Locked | Locked | Locked |
Digital supply and procurement management is offered for medical distributors.
|
Detailed competitors of Pharm Assess
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharm Assess
Complete news archive for Pharm Assess
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharm Assess
Pharm Assess was founded in 1996.
Pharm Assess is headquartered in Overland Park, United States. It is registered at Overland Park, Kansas, United States.
Sunil Kumar is the current CEO of Pharm Assess.
Pharm Assess was established in 1996 in Overland Park, United States, as a provider of digital tools tailored to the pharmaceutical sector. Software solutions are developed to support cost containment, business expansion, strategic planning, investment management, and workflow optimization. Operations focus on enhancing efficiency for pharmaceutical enterprises through integrated management features.
Pharm Assess's top competitors include One bio, Aptitude Health and Skila.
Pharm Assess offers Reconciliation, Premium Rx30, Telepharmacy, Vaccines, and Patient Engagement.
Pharm Assess has 1 investor. Key investors include Transaction Data Systems.